MENU
+Compare
SDZXF
Stock ticker: OTC
AS OF
Jun 17 closing price
Price
$51.98
Change
-$0.02 (-0.04%)

SDZXF Sandoz Group AG Forecast, Technical & Fundamental Analysis

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs... Show more

SDZXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SDZXF with price predictions
Jul 02, 2025

SDZXF's Stochastic Oscillator is sitting in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on SDZXF as a result. In of 20 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 107 cases where SDZXF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SDZXF turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 10 similar instances when the indicator turned negative. In of the 10 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SDZXF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (62.813). P/E Ratio (0.000) is within average values for comparable stocks, (89.433). SDZXF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (19.290).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SDZXF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
SDZXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SDZXF is expected to report earnings to fall 68.55% to 50 cents per share on March 13

Sandoz Group AG SDZXF Stock Earnings Reports
Q4'23
Est.
$0.50
Q4'24
Est.
$1.59
The last earnings report on March 05 showed earnings per share of $1.59, meeting the estimate of $1.59. With 4.41K shares outstanding, the current market capitalization sits at 0.00.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLNHP4.000.70
+21.21%
Soluna Holdings
NGVT46.792.39
+5.38%
Ingevity Corp
CTMX2.480.12
+5.08%
CytomX Therapeutics
DLB76.060.49
+0.65%
Dolby Laboratories IncClass A
UCL1.83-0.04
-2.14%
uCloudlink Group

SDZXF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SDZXF has been loosely correlated with SDZNY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SDZXF jumps, then SDZNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZXF
1D Price
Change %
SDZXF100%
N/A
SDZNY - SDZXF
44%
Loosely correlated
-0.68%
BNXTF - SDZXF
29%
Poorly correlated
+14.61%
AGYTF - SDZXF
20%
Poorly correlated
N/A
CBSTF - SDZXF
6%
Poorly correlated
-5.49%
ESAIY - SDZXF
5%
Poorly correlated
N/A
More

Groups containing SDZXF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZXF
1D Price
Change %
SDZXF100%
N/A
Pharmaceuticals
category (297 stocks)
13%
Poorly correlated
+0.85%
Pharmaceuticals: Other
category (203 stocks)
9%
Poorly correlated
+0.38%